[시장보고서]세계의 성인 이상 혈색소증 검사 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

세계의 성인 이상 혈색소증 검사 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Adult Hemoglobinopathy Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1631387

리서치사 : Persistence Market Research

발행일 : 2025년 01월

페이지 정보 : 영문 217 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,224,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,550,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,286,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 성인 이상 혈색소증 검사 시장 규모는 2025년 3억 8,210만 달러에 달할 것으로 보이며, 2025-2032년 예측기간에 4.4%의 연평균 복합 성장률(CAGR)로 확대되며, 2032년에는 5억 4,040만 달러에 도달할 것으로 예상됩니다.

성인 이상 혈색소증 검사는 겸상 적혈구증과 살라세미아 등 혈액 질환의 진단과 모니터링에 중요한 역할을 하고 있습니다. 다양한 검사 기술을 포함, 질병 병원, 진료소, 진단 실험실, 조사 현장을 위한 진단 솔루션을 제공합니다. 보다 빠르고 정확한 결과를 제공하는 검사 방법의 진보입니다.

세계의 성인 이상 혈색소증 검사 시장은 특히 겸상 적혈구증 등 유전성 질환이 만연하고 있는 아프리카, 중동, 아시아태평양 등 지역에서 혈색소증의 유병률 상승 등 몇 가지 중요 한 요인에 의해 추진되고 있습니다. 평가 솔루션 수요 증가에 기여하고 있습니다. 자동 검사 시스템과 비 침습적 검사법의 개발과 같은 기술적 진보는 검사 정밀도와 접근성을 향상시켜 시장 성장을 가속하고 있습니다. 증상의 스크리닝 프로그램과 신생아 스크리닝 노력이 증가하고 있다는 점도 시장의 보급을 뒷받침하고 있습니다.

성인 이상 혈색소증 검사 시장은 기술 혁신, 인구동향, 세계의 헬스케어 구상에 의해 큰 성장 기회가 가져옵니다. 접근성이 향상되고 검사 범위가 확대되는 새로운 기회가 탄생했습니다. 또한, 증상이 나타나기 전에 혈색소증을 특정하기 위한 분자진단이나 유전자 검사의 이용 확대가 수요를 견인하고 있습니다. 전략적 제휴와 검사법을 강화하기 위한 연구개발에 대한 투자가 필수적입니다.

본 보고서에서는 세계의 성인 이상 혈색소증 검사 시장에 대해 조사했으며, 이형 유형별, 검사 유형별, 최종 사용자별, 지역별 동향 및 시장 진출기업프로파일 등의 정보를 제공합니다.

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for adult hemoglobinopathy testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global adult hemoglobinopathy testing market from 2025 to 2032.

Key Insights:

Adult Hemoglobinopathy Testing Market Size (2025E): USD 382.1 Mn
Projected Market Value (2032F): USD 540.4 Mn
Global Market Growth Rate (CAGR 2025 to 2032): 4.4%

Adult Hemoglobinopathy Testing Market - Report Scope:

Adult hemoglobinopathy testing plays a critical role in the diagnosis and monitoring of blood disorders, such as sickle cell disease and thalassemia. The market includes a variety of testing technologies, including hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), and molecular diagnostics, offering diagnostic solutions for hospitals, clinics, diagnostic laboratories, and research settings. The market growth is driven by rising global awareness of hemoglobinopathies, increased government and private sector initiatives to support diagnostic technologies, and advancements in testing methods that provide faster and more accurate results.

Market Growth Drivers:

The global adult hemoglobinopathy testing market is propelled by several key factors, including an increasing prevalence of hemoglobinopathies, particularly in regions like Africa, the Middle East, and Asia Pacific, where genetic disorders such as sickle cell disease are widespread. Rising healthcare awareness, improved access to healthcare services, and growing research investments are contributing to the growing demand for testing solutions. Technological advancements, such as the development of automated testing systems and non-invasive testing methods, are enhancing testing accuracy and accessibility, thus fostering market growth. Moreover, the increasing number of screening programs and newborn screening initiatives for hemoglobinopathies are boosting market adoption.

Market Restraints:

Despite the promising growth prospects, the adult hemoglobinopathy testing market faces challenges related to high testing costs, limited access to advanced diagnostic tools in low-income regions, and the lack of standardized testing protocols across different countries. Additionally, limited reimbursement coverage for certain diagnostic tests and the complexity of some testing methods could restrict market growth, particularly in resource-constrained settings. These challenges require the development of affordable, accessible, and standardized testing solutions to expand the market reach and ensure effective disease management.

Market Opportunities:

The adult hemoglobinopathy testing market presents significant growth opportunities driven by technological innovations, demographic trends, and global healthcare initiatives. The development of more cost-effective, portable, and user-friendly diagnostic devices is creating new opportunities to improve accessibility and expand testing reach. Furthermore, the expanding use of molecular diagnostics and genetic testing to identify hemoglobinopathies before symptoms appear is driving demand. Strategic collaborations between industry players and healthcare providers, as well as investments in research and development to enhance testing methods, will be crucial for capitalizing on these opportunities.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the adult hemoglobinopathy testing market globally?
Which testing technologies are most widely used in the diagnosis of hemoglobinopathies, and how are they evolving?
How are advancements in diagnostic technologies reshaping the competitive landscape of the adult hemoglobinopathy testing market?
Who are the key players contributing to the adult hemoglobinopathy testing market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global adult hemoglobinopathy testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global adult hemoglobinopathy testing market, such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, and Beckman Coulter, Inc., focus on product innovation, strategic partnerships, and expanding their market reach. These companies invest in R&D to develop advanced testing solutions, including automated and portable diagnostic systems, to cater to diverse patient needs and healthcare settings. Collaborations with hospitals, diagnostic laboratories, and healthcare organizations help facilitate market access and enhance technology adoption. Furthermore, companies are increasingly focusing on regional expansion, particularly in emerging markets, to capture a larger share of the market.

Key Companies Profiled:

Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific
Beckman Coulter, Inc.
Abbott Laboratories
Agilent Technologies, Inc.
Sebia S.A.
Ortho Clinical Diagnostics
Siemens Healthineers
HemoTypeS
Helena Laboratories Corporation

The Adult Hemoglobinopathy Testing Market is Segmented Based on:

Variant Type

Variant A2
Variant F

Test Type

HPLC Test
Mass Spectrometry
Hb electrophoresis

End Users

Hospitals
Reference Laboratories
Academic & Medical institutes

Region

North America
Latin America
Europe
Asia Pacific
Japan
Japan and Middle-East
Africa

1. Executive Summary

1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Definition
2.2. Market Taxonomy

3. Adult Hemoglobinopathy Testing Market Opportunity Analysis

3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background

4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Trends
4.2. Reimbursement Scenario
4.3. Regional Pricing Analysis by Test Type (2024)
4.4. Disease Epidemiology (2024)

5. North America Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032

5.1. Introduction
5.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2024
- 5.2.1. U.S.
- 5.2.2. Canada
5.3. Market Size (US$ Mn) Forecast By Country, 2025 - 2032
5.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2019 - 2024
- 5.4.1. Hemoglobin F
- 5.4.2. Hemoglobin A2
5.5. Market Size (US$ Mn) Forecast By Variant Type, 2025 - 2032
5.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2019 - 2024
- 5.6.1. HPLC Test
- 5.6.2. Hb Electrophoresis
- 5.6.3. Mass Spectrometry
5.7. Market Size (US$ Mn) Forecast By Test Type, 2025 - 2032
5.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019 - 2024
- 5.8.1. Reference Laboratories
- 5.8.2. Hospitals
- 5.8.3. Academic and Medical Institutes
5.9. Market Size (US$ Mn) Forecast By End User, 2025 - 2032
5.10. Market Attractiveness Analysis
- 5.10.1. By Country
- 5.10.2. By Variant Type
- 5.10.3. By Test Type
- 5.10.4. By End User
5.11. Drivers and Restraints - Impact Analysis

6. Latin America Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032

6.1. Introduction
6.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2019 - 2024
- 6.2.1. Brazil
- 6.2.2. Mexico
- 6.2.3. Rest of Latin America
6.3. Market Size (US$ Mn) Forecast By Country, 2025 - 2032
6.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2019 - 2024
- 6.4.1. Hemoglobin F
- 6.4.2. Hemoglobin A2
6.5. Market Size (US$ Mn) Forecast By Variant Type, 2025 - 2032
6.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2019 - 2024
- 6.6.1. HPLC Test
- 6.6.2. Hb Electrophoresis
- 6.6.3. Mass Spectrometry
6.7. Market Size (US$ Mn) Forecast By Test Type, 2025 - 2032
6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019 - 2024
- 6.8.1. Reference Laboratories
- 6.8.2. Hospitals
- 6.8.3. Academic and Medical Institutes
6.9. Market Size (US$ Mn) Forecast By End User, 2025 - 2032
6.10. Market Attractiveness Analysis
- 6.10.1. By Country
- 6.10.2. By Variant Type
- 6.10.3. By Test Type
- 6.10.4. By End User
6.11. Drivers and Restraints - Impact Analysis

7. Europe Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032

7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2019 - 2024
- 7.2.1. Germany
- 7.2.2. U.K.
- 7.2.3. France
- 7.2.4. Italy
- 7.2.5. Spain
- 7.2.6. Rest of Europe
7.3. Market Size (US$ Mn) Forecast By Country, 2025 - 2032
7.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2019 - 2024
- 7.4.1. Hemoglobin F
- 7.4.2. Hemoglobin A2
7.5. Market Size (US$ Mn) Forecast By Variant Type, 2025 - 2032
7.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2019 - 2024
- 7.6.1. HPLC Test
- 7.6.2. Hb Electrophoresis
- 7.6.3. Mass Spectrometry
7.7. Market Size (US$ Mn) Forecast By Test Type, 2025 - 2032
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019 - 2024
- 7.8.1. Reference Laboratories
- 7.8.2. Hospitals
- 7.8.3. Academic and Medical Institutes
7.9. Market Size (US$ Mn) Forecast By End User, 2025 - 2032
7.10. Market Attractiveness Analysis
- 7.10.1. By Country
- 7.10.2. By Variant Type
- 7.10.3. By Test Type
- 7.10.4. By End User
7.11. Drivers and Restraints - Impact Analysis

8. Asia Pacific Excluding Japan Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032

8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2019 - 2024
- 8.2.1. China
- 8.2.2. India
- 8.2.3. Australia and New Zealand
- 8.2.4. Rest of Asia Pacific
8.3. Market Size (US$ Mn) Forecast By Country, 2025 - 2032
8.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2019 - 2024
- 8.4.1. Hemoglobin F
- 8.4.2. Hemoglobin A2
8.5. Market Size (US$ Mn) Forecast By Variant Type, 2025 - 2032
8.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2019 - 2024
- 8.6.1. HPLC Test
- 8.6.2. Hb Electrophoresis
- 8.6.3. Mass Spectrometry
8.7. Market Size (US$ Mn) Forecast By Test Type, 2025 - 2032
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019 - 2024
- 8.8.1. Reference Laboratories
- 8.8.2. Hospitals
- 8.8.3. Academic and Medical Institutes
8.9. Market Size (US$ Mn) Forecast By End User, 2025 - 2032
8.10. Market Attractiveness Analysis
- 8.10.1. By Country
- 8.10.2. By Variant Type
- 8.10.3. By Test Type
- 8.10.4. By End User
8.11. Drivers and Restraints - Impact Analysis

9. Japan Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032

9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2019 - 2024
- 9.2.1. Hemoglobin F
- 9.2.2. Hemoglobin A2
9.3. Market Size (US$ Mn) Forecast By Variant Type, 2025 - 2032
9.4. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2019 - 2024
- 9.4.1. HPLC Test
- 9.4.2. Hb Electrophoresis
- 9.4.3. Mass Spectrometry
9.5. Market Size (US$ Mn) Forecast By Test Type, 2025 - 2032
9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019 - 2024
- 9.6.1. Reference Laboratories
- 9.6.2. Hospitals
- 9.6.3. Academic and Medical Institutes
9.7. Market Size (US$ Mn) Forecast By End User, 2025 - 2032
9.8. Market Attractiveness Analysis
- 9.8.1. By Variant Type
- 9.8.2. By Test Type
- 9.8.3. By End User
9.9. Drivers and Restraints - Impact Analysis

10. Middle East & Africa Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032

10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2019 - 2024
- 10.2.1. GCC Countries
- 10.2.2. South Africa
- 10.2.3. Rest of MEA
10.3. Market Size (US$ Mn) Forecast By Country, 2025 - 2032
10.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2019 - 2024
- 10.4.1. Hemoglobin F
- 10.4.2. Hemoglobin A2
10.5. Market Size (US$ Mn) Forecast By Variant Type, 2025 - 2032
10.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2019 - 2024
- 10.6.1. HPLC Test
- 10.6.2. Hb Electrophoresis
- 10.6.3. Mass Spectrometry
10.7. Market Size (US$ Mn) Forecast By Test Type, 2025 - 2032
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019 - 2024
- 10.8.1. Reference Laboratories
- 10.8.2. Hospitals
- 10.8.3. Academic and Medical Institutes
10.9. Market Size (US$ Mn) Forecast By End User, 2025 - 2032
10.10. Market Attractiveness Analysis
- 10.10.1. By Country
- 10.10.2. By Variant Type
- 10.10.3. By Test Type
- 10.10.4. By End User
10.11. Drivers and Restraints - Impact Analysis

11. Forecast Assumptions

12. Competition Analysis

12.1. Competition Dashboard
12.2. Company Deep Dive
- 12.2.1. Bio-Rad Laboratories, Inc.
  - 12.2.1.1. Overview
  - 12.2.1.2. Product and Application Portfolio
  - 12.2.1.3. Production Footprint
  - 12.2.1.4. Sales Footprint
  - 12.2.1.5. Channel Footprint
  - 12.2.1.6. Strategy
    - 12.2.1.6.1. Marketing Strategy
    - 12.2.1.6.2. Product Strategy
    - 12.2.1.6.3. Channel Strategy
- 12.2.2. Thermo Fisher Scientific Inc.
  - 12.2.2.1. Overview
  - 12.2.2.2. Product and Application Portfolio
  - 12.2.2.3. Production Footprint
  - 12.2.2.4. Sales Footprint
  - 12.2.2.5. Channel Footprint
  - 12.2.2.6. Strategy
    - 12.2.2.6.1. Marketing Strategy
    - 12.2.2.6.2. Product Strategy
    - 12.2.2.6.3. Channel Strategy
- 12.2.3. PerkinElmer Inc.
  - 12.2.3.1. Overview
  - 12.2.3.2. Product and Application Portfolio
  - 12.2.3.3. Production Footprint
  - 12.2.3.4. Sales Footprint
  - 12.2.3.5. Channel Footprint
  - 12.2.3.6. Strategy
    - 12.2.3.6.1. Marketing Strategy
    - 12.2.3.6.2. Product Strategy
    - 12.2.3.6.3. Channel Strategy
- 12.2.4. Chromsystems Instruments & Chemicals GmbH
  - 12.2.4.1. Overview
  - 12.2.4.2. Product and Application Portfolio
  - 12.2.4.3. Production Footprint
  - 12.2.4.4. Sales Footprint
  - 12.2.4.5. Channel Footprint
  - 12.2.4.6. Strategy
    - 12.2.4.6.1. Marketing Strategy
    - 12.2.4.6.2. Product Strategy
    - 12.2.4.6.3. Channel Strategy
- 12.2.5. BioMedomics, Inc
  - 12.2.5.1. Overview
  - 12.2.5.2. Product and Application Portfolio
  - 12.2.5.3. Production Footprint
  - 12.2.5.4. Sales Footprint
  - 12.2.5.5. Channel Footprint
  - 12.2.5.6. Strategy
    - 12.2.5.6.1. Marketing Strategy
    - 12.2.5.6.2. Product Strategy
    - 12.2.5.6.3. Channel Strategy
- 12.2.6. CapitalBio Technology Inc
  - 12.2.6.1. Overview
  - 12.2.6.2. Product and Application Portfolio
  - 12.2.6.3. Production Footprint
  - 12.2.6.4. Sales Footprint
  - 12.2.6.5. Channel Footprint
  - 12.2.6.6. Strategy
    - 12.2.6.6.1. Marketing Strategy
    - 12.2.6.6.2. Product Strategy
    - 12.2.6.6.3. Channel Strategy
- 12.2.7. Trinity Biotech
  - 12.2.7.1. Overview
  - 12.2.7.2. Product and Application Portfolio
  - 12.2.7.3. Production Footprint
  - 12.2.7.4. Sales Footprint
  - 12.2.7.5. Channel Footprint
  - 12.2.7.6. Strategy
    - 12.2.7.6.1. Marketing Strategy
    - 12.2.7.6.2. Product Strategy
    - 12.2.7.6.3. Channel Strategy
- 12.2.8. Streck, Inc .
  - 12.2.8.1. Overview
  - 12.2.8.2. Product and Application Portfolio
  - 12.2.8.3. Production Footprint
  - 12.2.8.4. Sales Footprint
  - 12.2.8.5. Channel Footprint
  - 12.2.8.6. Strategy
    - 12.2.8.6.1. Marketing Strategy
    - 12.2.8.6.2. Product Strategy
    - 12.2.8.6.3. Channel Strategy

13. Global Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Region

13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2019 - 2024
13.3. Market Size (US$ Mn) Forecast By Region, 2025 - 2032
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. Asia Pacific
- 13.3.5. Middle East & Africa
13.4. Market Attractiveness Analysis By Region

14. Global Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Variant Type

14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2019 - 2024
- 14.2.1. Hemoglobin F
- 14.2.2. Hemoglobin A2
14.3. Market Size (US$ Mn) Forecast By Variant Type, 2025 - 2032
14.4. Key Market Attractiveness Analysis

15. Global Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Test Type

Classification of Test Type; highlighting historical trends, current market value, and future projections on the basis of key segments

15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2019 - 2024
- 15.2.1. HPLC Test
- 15.2.2. Hb Electrophoresis
- 15.2.3. Mass Spectrometry
15.3. Market Size (US$ Mn) Forecast By Test Type, 2025 - 2032
15.4. Market Attractiveness Analysis

16. Global Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By End User

16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019 - 2024
- 16.2.1. Reference Laboratories
- 16.2.2. Hospitals
- 16.2.3. Academic and Medical Institutes
16.3. Market Size (US$ Mn) Forecast By End User, 2025 - 2032
16.4. Market Attractiveness Analysis

17. Global Adult Hemoglobinopathy Testing Market Analysis 2019 - 2024 and Forecast 2025 - 2032

17.1. Market Value (US$ Mn) Projections
17.2. Y-o-Y Growth Analysis
17.3. Absolute $ Opportunity
17.4. Research Methodology

한글목차

목차

제1장 주요 요약

제2장 시장 소개

제3장 성인 이상 혈색소증 검사 시장 기회 분석

제4장 시장 배경

제5장 북미의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년)

제6장 라틴아메리카의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년)

제7장 유럽의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년)

제8장 아시아태평양(일본 제외)의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년)

제9장 일본의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년)

제10장 중동 및 아프리카의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년)

제11장 예측의 전제조건

제12장 경쟁 분석

제13장 세계의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년), 지역별

제14장 세계의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년), 이형 유형별

제15장 세계의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년), 검사 유형별

제16장 세계의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년), 최종 사용자별

제17장 세계의 성인 이상 혈색소증 검사 시장 분석(2019-2024년) 및 예측(2025-2032년)